Clinical Trial Management Systems Market - Growth, Trends, and Forecast (2020 - 2025)

The Clinical Trial Management Systems Market is segmented by Delivery Mode, Component, End User (Pharmaceuticals, Clinical Research Organization, Other End Users), Type of System, and Geography.

Market Snapshot

Study Period:


Base Year:


Fastest Growing Market:

Asia Pacific

Largest Market:

North America


8.7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Although the clinical trial management systems market has been in its nascent stage for the last decade years, it has currently established itself as a mature market in the North American region. Asia-Pacific is still experiencing a growth steadily to achieve maturity, when compared to developed regions. This is mainly attributed to increasing clinical trials due to the good availability of inexpensive resources and increasing population pool in these regions. Moreover, the increased adoption of clinical trial management systems in the past few years has been a major factor that is contributing to the growth of this market.

Many companies that have developed clinical trial management systems have found a way to integrate with the existing software providers, in order to provide an efficient workflow in clinical trial management.

The increasing innovative technological advancements to curb the increasing costs associated with clinical trials have resulted in the development of the clinical trial management system. Although these systems have not been completely adapted due to various factors, the increasing awareness and the need to cut down additional costs associated with clinical trials are expected to drive the market in the coming years. Increasing R&D and the rise in the number of clinical trials in the Asian region are expected to further contribute to the growth of the market studied, during the forecast period.

Scope of the Report

As per the scope of the report, a Clinical Trial Management System is a software system used to manage clinical trials in clinical research. The system maintains and manages planning, performing and reporting functions, along with participant contact information, tracking deadlines and milestones

By Delivery Mode
Web-based and Cloud-based Clinical Trial Management System
On-premise Clinical Trial Management System
By Component
By End User
Contract Research Organization
Other End Users
By Type of System
Site-based Clinical Trial Management System
Licensed Enterprise-based Clinical Trial Management System
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Use in Pharmaceutical sector is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Pharmaceutical companies use clinical trial management systems to manage clinical trials as part of their pharmaceutical and biotechnology research activities. This type of software is used by researchers to define, implement, and track results of clinical trials. Administrative personnel of clinical trials also use this type of application to find and schedule participants, and track their involvement in the trials.

The use of this comprehensive software and services has increased among pharmaceutical industries due to increased funding over the years. The global pharmaceutical industry investment in research and development has increased over the years, from USD 108.1 billion in 2006 to USD 156.7 billion in 2016, as per a 2017 report by the Association of the British Pharmaceutical Industry. This translates to more spending on clinical trials and its management as well. This has helped the market growth in recent years, and with the continuing trend, is expected to boost the future growth of the market as well.

To understand key trends, Download Sample Report

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall clinical trial management systems market, with the United States emerging as the major contributor to the market. Factors, such as increasing R&D investments and a rise in the demand for drug development, are aiding the growth of the market studied in the country. R&D budgets of the pharmaceutical companies have also increased in the last few years, owing to the increasing focus on regulating markets, complex molecules, and therapy segments. In the United States, pharmaceutical companies spend more money, time, and energy on R&D than others. Thus, the rise in research and clinical trials in the region is expected to increase the demand for clinical trial management systems, which, in turn, is expected to aid the growth of the market studied in the United States, over the forecast period.

To understand geography trends, Download Sample Report.

Competitive Landscape

The presence of major market players, such as Bio-Optronics Inc., MedNet Solutions Inc., Oracle, Parexel International Corporation, and IBM, is, in turn, increasing the overall competitive rivalry of the market. Large organizations rely heavily on advertising expenses and branding strategies, collaborations, initiatives or programs at national levels, which promote their product, and thus, get recognized earlier than other brands in the market. With the high prevalence rate of diseases, the intensity of competitive rivalry in the market is increasing over time.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Chronic Diseases and Lifestyle-related Disorders Patients Population

      2. 4.2.2 Rise in Outsourcing of Clinical Trials and Implementation by Contract Research Organizations

    3. 4.3 Market Restraints

      1. 4.3.1 Data Security Issues

      2. 4.3.2 High Cost and Securuty Issues Associated with CTMS

    4. 4.4 Industry Attractiveness- Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Delivery Mode

      1. 5.1.1 Web-based and Cloud-based Clinical Trial Management System

      2. 5.1.2 On-premise Clinical Trial Management System

    2. 5.2 By Component

      1. 5.2.1 Software

      2. 5.2.2 Services

    3. 5.3 By End User

      1. 5.3.1 Pharmaceuticals

      2. 5.3.2 Contract Research Organization

      3. 5.3.3 Other End Users

    4. 5.4 By Type of System

      1. 5.4.1 Site-based Clinical Trial Management System

      2. 5.4.2 Licensed Enterprise-based Clinical Trial Management System

    5. 5.5 Geography

      1. 5.5.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.5.2 Europe

        1. United Kingdom

        2. Germany

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.5.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.5.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Bioclinica

      2. 6.1.2 Bio-Optronics Inc.

      3. 6.1.3 DATATRAK International Inc.

      4. 6.1.4 ERT Clinical

      5. 6.1.5 IBM

      6. 6.1.6 Medidata Solutions Inc.

      7. 6.1.7 MedNet Solutions Inc.

      8. 6.1.8 Oracle

      9. 6.1.9 Parexel International Corporation

      10. 6.1.10 ArisGlobal

  7. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports